These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13971779)

  • 1. The contact phase of coagulation in the presence of heparin.
    BLOOM AL
    J Clin Pathol; 1962 Nov; 15(6):508-10. PubMed ID: 13971779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.
    RATNOFF OD; DAVIE EW; MALLETT DL
    J Clin Invest; 1961 May; 40(5):803-19. PubMed ID: 13739760
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI).
    Ratnoff OD
    J Lab Clin Med; 1972 Nov; 80(5):704-10. PubMed ID: 4673237
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of factors XII (Hageman) and XI (PTA) by skin contact.
    Nossel HL
    Proc Soc Exp Biol Med; 1966 May; 122(1):16-7. PubMed ID: 5944866
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammatory process in acute gouty arthritis. II. The presence of Hageman factor and plasma thromboplastin antecedent in synovial fluid.
    Kellermeyer RW; Breckenridge RT
    J Lab Clin Med; 1966 Mar; 67(3):455-60. PubMed ID: 5910152
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood coagulation. Role of Hageman protein (F-XII) and autoprothrombin II (F-IX?) in the activation of autoprothrombin 3 (F-X).
    Seegers WH; Grammens GL; McCoy LE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):345-51. PubMed ID: 5533980
    [No Abstract]   [Full Text] [Related]  

  • 9. Separation of plasma thromboplastin antecedent (PTA) and Hageman factor (HF) from human plasma.
    SCHIFFMAN S; RAPAPORT SI; WARE AG; MEHL JW
    Proc Soc Exp Biol Med; 1960 Dec; 105():453-5. PubMed ID: 13747627
    [No Abstract]   [Full Text] [Related]  

  • 10. OBSERVATIN OF FACTOR XII AND FACTOR XII DEFICIENT PLASMA AT AN INTERFACE.
    ADAMS AL; VROMAN L
    Thromb Diath Haemorrh; 1965 Jun; 13():387-93. PubMed ID: 14347862
    [No Abstract]   [Full Text] [Related]  

  • 11. STASIS THROMBI INDUCED BY BACTERIAL ENDOTOXIN.
    THOMAS DP; WESSLER S
    Circ Res; 1964 Jun; 14():486-93. PubMed ID: 14169967
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of Hageman factor activation.
    Nossel HL; Rubin H; Drillings M; Hsieh R
    J Clin Invest; 1968 May; 47(5):1172-80. PubMed ID: 5645860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contact activation of Hageman factor and the interaction of Hageman factor and plasma thromboplastin antecedent.
    Haanen C; Morselt G; Schoenmakers J
    Thromb Diath Haemorrh; 1967 May; 17(3-4):307-20. PubMed ID: 5626768
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BLOOD CLOTTING FACTOR IN HEMOLYSATES].
    OGIWARA Y
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():779-87. PubMed ID: 14154695
    [No Abstract]   [Full Text] [Related]  

  • 17. [INDICATIONS FOR FRESH BLOOD AND PRESERVED BLOOD IN DEFICIENCIES OF BLOOD COAGULATION FACTORS].
    SOULIER JP
    Transfusion (Paris); 1964; 7():253-6. PubMed ID: 14212678
    [No Abstract]   [Full Text] [Related]  

  • 18. The possible role of platelets in bypassing the contact phase of blood coagulation.
    Walsh PN; Tuszynski GP; Greengard JS; Griffin JH
    Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of PTA (factor XI) and Hageman factor (factor XII).
    Ratnoff OD; Botti RE; Crum JD; Donaldson VH
    Thromb Diath Haemorrh Suppl; 1965; 17():1-14. PubMed ID: 5335359
    [No Abstract]   [Full Text] [Related]  

  • 20. [STUDIES ON THE ANTECEDENT FACTORS XI AND XII IN NEWBORN AND YOUNG INFANTS].
    BRUESTER H
    Z Kinderheilkd; 1964 Nov; 91():139-43. PubMed ID: 14334644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.